CD47 Protein Products for Cancer and Cardiovascular Research
Oct 24 2017 Read 251 Times
Amsbio has announced a new range of CD47-relevant products suitable for rapid high throughput screening studies.
CD47, or Integrin associated protein (IAP), is a transmembrane protein that in humans is encoded by the CD47 gene. Studies have established that CD47 is involved in a range of cellular processes, including apoptosis, proliferation, adhesion and migration. Furthermore, CD47 is known to be a key regulator of tissue homeostasis, and is also involved in a variety of diseases ranging from atherosclerosis to cancer. Given its significant role in pathogenesis of cancer and cardiovascular diseases, CD47 signalling has been heavily investigated for new targeted therapeutics.
The unique set of CD47-relevant products from Amsbio includes human CD47 protein and multiple avi tag pre-biotinylated proteins. Derived from Human (HEK 293) cells, Amsbio CD47 protein products demonstrate superb bioactivity, high detection sensitivity and authentic post translational modification and protein conformation. The new Amsbio CD47 protein kits are supplied as pairs of products that can be easily adapted to ELISA, AlphaLISA™ and MSD platforms to facilitate rapid and easy screening of the neutralising compound.
The CD47 protein product range is an exciting addition to Amsbio's exclusive biotinylated protein collection which is specially designed to simplify your research.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles Chromatography - Visiting the 15th International Symposium - New Application Book Offers Expertise in GPC Analysis - Same Separation, Speedier Solution Mass S...
View all digital editions
Mar 23 2018 Beijing, China
Mar 27 2018 Guangzhou, China
Mar 28 2018 Lyon, France
Apr 02 2018 Suntec City, Singapore
Apr 04 2018 Jakarta, Indonesia